Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fpr-rs6 Inhibitors

Chemical classes categorized as Fpr-rs6 inhibitors consist of diverse compounds that act upon the signaling pathways and cellular processes potentially linked to the Fpr-rs6 protein. These substances interact with different molecular targets that are part of or connected to the signaling networks in which Fpr-rs6 participates. As Fpr-rs6 is a GPCR, its primary function is to transduce extracellular signals into cellular responses, commonly through the activation of downstream G proteins and subsequent signaling cascades. Inhibitors like Boc-MLF and WRW4 target related GPCRs, presuming that their antagonistic effects can extend to Fpr-rs6 by preventing ligand-receptor interactions and receptor activation.

Other molecules such as Cyclosporin A and Pertussis Toxin alter the activity of proteins involved in secondary messenger systems, such as calcineurin and the Gi protein of GPCRs, respectively. These alterations can attenuate or modify the signal transduction processes that Fpr-rs6 might initiate or modulate. Additionally, compounds like PD 98059, LY294002, and Wortmannin intervene in kinase signaling pathways, specifically targeting MEK, PI3K, and related enzymes, which are often downstream effectors in GPCR-mediated signaling. Their inhibitory action on these kinases can result in the modulation of various cellular responses, potentially including those orchestrated by Fpr-rs6.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Cyclosporin A, an immunosuppressant, can inhibit calcineurin and thus may affect Fpr-rs6 related pathways that involve calcium signaling.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Pertussis toxin can inhibit G protein-coupled receptors by ADP-ribosylating the Gi subunit, which may indirectly affect Fpr-rs6 signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 is an inhibitor of MEK, which can block the MAPK/ERK pathway, potentially affecting downstream processes of Fpr-rs6 signaling.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can disrupt the PI3K/Akt pathway, which might be involved in the signaling cascade of Fpr-rs6.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

Gö 6983 is a protein kinase C inhibitor that can alter various cellular processes, potentially including those regulated by Fpr-rs6.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB 203580 is a p38 MAPK inhibitor that can modify inflammatory responses, which Fpr-rs6 may be a part of.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that can suppress the PI3K/Akt pathway, thus possibly affecting Fpr-rs6 signaling.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

ML141 is a Cdc42 inhibitor, a small GTPase, which can influence actin cytoskeleton remodeling involved in Fpr-rs6 mediated cell migration.

Ro 31-8220

138489-18-6sc-200619
sc-200619A
1 mg
5 mg
$92.00
$245.00
17
(1)

Ro-31-8220 is a broad-spectrum protein kinase inhibitor, including protein kinase C, which can affect signaling pathways linked with Fpr-rs6.